Johnson & Johnson
Most Read
Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures
What happens when the government stops buying Covid-19 vaccines?
Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER
Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Google taps FDA’s former digital health chief for global strategy role
FDA rejects antidepressant seen as possible Covid-19 treatment
Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
All Coverage
advertisement
